Question explored with the scientific record
Conversation so far
- 1 Vitamin K
- 2 Vitamin K why is it given at birth to all babies
Answered on this page ↓
Vitamin K why is it given at birth to all babies
The shot exists to stop a rare but catastrophic brain bleed, and it works. The honest caveats are about the injection, not the vitamin.
Newborns are born with low vitamin K and little of it in breast milk, so a few develop vitamin K deficiency bleeding, including bleeding into the brain. Before routine prophylaxis, the classic form was reported at about 4 per 1,000 births [4]. Late bleeding, the dangerous kind that strikes weeks later in exclusively breastfed babies, ran at roughly 4.4 to 7.2 per 100,000 births [2]. In Germany it fell from about 4.8 to 0.42 per 100,000 after prophylaxis, and 58% of those cases were bleeds in the skull with a 19% death rate [8]. A Japanese program using oral vitamin K2 dropped brain bleeds from about 1 in 3,500 to roughly 1 in 68,500 [5].
| Finding | Before prophylaxis | With prophylaxis |
|---|---|---|
| Late bleeding, Germany | 4.8 per 100,000 [8] | 0.42 per 100,000 [8] |
| Brain bleed, Japan | 1 in 3,500 [5] | 1 in 68,500 [5] |
| Late bleeding, per 100,000 | 4.4 to 7.2 [2] | near zero with the shot [2] |
That is a real benefit, and it is why the shot is universal. The catch is that the evidence is almost entirely observational, comparing countries and eras, not randomized trials against untreated babies [2][5][8]. The one randomized trial here found oral and injected vitamin K performed the same on clotting markers, with no bleeding difference [6]. Oral regimens need repeat doses to match the shot [3][7]. Minor reactions were rare in one small study: rash in 2 of 103 babies, hives in 1 [1].
My call: the benefit is real and the risk of the bleeding is real, so the shot is defensible for most babies; the choice of route and the right to decline should stay with the parent. Confidence: moderate.
Sources used 8
-
Vitamin K Prophylaxis in Newborn: Current Hospital Practices in a Metropolitan City
In an observational study of 103 newborns in Chittagong, vitamin K prophylaxis was predominantly oral (86.41%) rather than the recommended intramuscular route, and 20.39% received it before breastfeeding initiation.
DOI: 10.3329/jcmcta.v27i1.62283 -
Controversies Concerning Vitamin K and the Newborn
This paper discusses the prevention of vitamin K deficiency bleeding (VKDB) in newborns, emphasizing the effectiveness of parenteral vitamin K administration and addressing concerns about its association with childhood cancer.
DOI: 10.1542/peds.112.1.191 -
Use of Oral Vitamin K for Prevention of Late Vitamin K Deficiency Bleeding in Neonates When Injectable Vitamin K is Not Available
This study evaluates the effectiveness of oral vitamin K regimens for preventing late vitamin K deficiency bleeding (VKDB) in neonates when injectable vitamin K is unavailable, highlighting the need for multiple doses, especially in exclusively breast-fed infants.
DOI: 10.1345/aph.1Q769 -
Three Infant Care Interventions: Reconsidering the Evidence
This study critically evaluates three common neonatal care interventions—blood sampling, ophthalmia neonatorum prophylaxis, and vitamin K administration—highlighting the need for evidence-based practices to minimize pain and discomfort in newborns.
DOI: 10.1111/j.1552-6909.2002.tb00082.x -
Prophylaxis of intracranial hemorrhage due to vitamin K deficiency in infants
An epidemiological surveillance study in Nagasaki Prefecture showing that oral prophylaxis with vitamin K2 (2 mg at birth and 4 mg at 1 week) dramatically reduced intracranial hemorrhage due to vitamin K deficiency in breast-fed infants, with incidence dropping to about 1 in 68,…
DOI: 10.1016/s0387-7604(87)80050-5 -
Vitamin K to Neonates: Peroral versus Intramuscular Administration
This study compares the efficacy of 1 mg of peroral versus intramuscular vitamin K administration in preventing classical hemorrhagic disease of the newborn in a randomized trial of 300 infants, finding no significant differences in biochemical markers or bleeding events between…
DOI: 10.1111/j.1651-2227.1991.tb11853.x -
Neonatal vitamin K prophylaxis in Denmark: three years' experience with oral administration during the first three months of life compared with one oral administration at birth
This study evaluates the effectiveness of a new oral vitamin K prophylaxis regimen in Denmark, which involves administering 2 mg at birth followed by 1 mg weekly for three months, resulting in no reported cases of late vitamin K deficiency bleeding compared to previous regimens.
DOI: 10.1111/j.1651-2227.1996.tb18216.x -
Late form of Vitamin K Deficiency Bleeding in Germany
This study evaluates the late form of Vitamin K Deficiency Bleeding (VKDB) in Germany, highlighting its occurrence predominantly in fully breastfed male infants, the diagnostic criteria, and the effectiveness of Vitamin K prophylaxis in reducing incidence and severity.
DOI: 10.1055/s-2008-1046519